Company page
Antengene Corporation Limited
Antengene Corporation Limited, trading under the ticker 6996 on the Hong Kong Stock Exchange, is a public company with a market capitalization of approximately HKD 274.95 million. The company focuses on the development and commercialization of innovative cancer therapies. Antengene aims to address unmet medical needs in oncology through its advanced research and development efforts.
- Ticker
- 6996:HKEX
- Asset type
- Stock
- Market cap
- $275.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD